BioConference Live for the Life Science and Biotech Community

2-3 June 2010.
BioConference Live is an information break through and the first of its kind online-only conference for the life sciences and laboratory science community. This FREE event will feature live video keynote presentations from life science thought leaders where attendees can have their question answered by presenters in real time.

In addition, BioConference Live will feature a virtual exhibit hall, track sessions and case studies, and poster sessions where researchers present and discuss their latest work.

Topics Include:

  • Chemistry
  • Biotechnology
  • Cancer Research
  • Cellular Biology
  • Drug Discovery
  • Genetics
  • Immunology
  • Lab Automation
  • Medicine
  • Molecular Biology
  • Neuroscience
  • Venture Capital

Register and participate in over 50 Live keynote and track presentations from speakers such as Dr. David Wolf M.D. NASA Astronaut and Medical Doctor, Steven Burrill CEO of Burrill & Company, Kevin Hrusovsky M.B.A. CEO of Caliper Life Sciences, and Dr. Paul Schoemaker, Ph.D. Chairman and CEO Decision Strategies International, Inc., The Wharton School.

For further information and registration, please visit:
http://bioconferencelive.com

Most Popular Now

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Discovery of anti-cancer chemistry makes skullcap …

The evolutionary secrets that enable the medicinal herb known as barbed skullcap to produce cancer fighting compounds have been unlocked by a collaboration of UK and Chin...

A soybean protein blocks LDL cholesterol productio…

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study...